Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Selective Omission of Axillary Surgery in Distinct Responders With Triple-negative and HER2-positive Breast Cancer After NACT

NCT05314114 is registered in ClinicalTrials.gov with Peking University as lead sponsor.

NCT NCT05314114
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05314114 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Selective Omission of Axillary Surgery in Distinct Responders With Triple-negative and HER2-positive Breast Cancer After NACT
Lead sponsor
Peking University
Phase
Not applicable
Overall status
Recruiting
Start date
July 3, 2020
Completion date
September 30, 2028
Enrollment
136 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer female